Simvastatin versus atorvastatin for improving mild to moderate depression in post-coronary artery bypass graft patients: A double-blind, placebo-controlled, randomized trial

Journal of Affective Disorders

Volumn 183, Issue , 2015, Pages 149-155

  Abbasi, Seyed Hesameddin ^a,b   Mohammadinejad, Payam ^c   Shahmansouri, Nazila ^a   Salehiomran, Abbas ^a   Beglar, Akram Arjmandi ^a   Zeinoddini, Atefeh ^c   Forghani, Saeedeh ^d   Akhondzadeh, Shahin ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Iranian Petroleum Industry Health Research Institute   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d RAZI VACCINE AND SERUM RESEARCH INSTITUTE   (Iran)

Author keywords

Atorvastatin; Coronary artery bypass; Depression; Simvastatin

Indexed keywords

ATORVASTATIN; PLACEBO; SIMVASTATIN; ANTIDEPRESSANT AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ANTIDEPRESSANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; COMPARATIVE EFFECTIVENESS; CONSTIPATION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DAYTIME SOMNOLENCE; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HAMILTON DEPRESSION RATING SCALE; HUMAN; LOSS OF APPETITE; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PARALLEL DESIGN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; XEROSTOMIA; ADVERSE EFFECTS; AGED; PERCUTANEOUS CORONARY INTERVENTION; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; ATORVASTATIN CALCIUM; CORONARY ARTERY BYPASS; DEPRESSION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; SEVERITY OF ILLNESS INDEX; SIMVASTATIN; TREATMENT OUTCOME;

EID: 84929573925     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2015.04.049     Document Type: Article

References (51)

1. S.H. Abbasi, F. Hosseini, A. Modabbernia, M. Ashrafi, and S. Akhondzadeh Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study J. Affect. Disord. 141 2-3 2012 308 314
2. C. Bernick, R. Katz, N.L. Smith, S. Rapp, R. Bhadelia, M. Carlson, L. Kuller, and Cardiovascular Health Study Collaborative Research, G Statins and cognitive function in the elderly: the Cardiovascular Health Study Neurology 65 2005 1388 1394
3. J.A. Blumenthal, H.S. Lett, M.A. Babyak, W. White, P.K. Smith, D.B. Mark, R. Jones, J.P. Mathew, M.F. Newman, and N. Investigators Depression as a risk factor for mortality after coronary artery bypass surgery Lancet 362 2003 604 609
4. J. Bosel, F. Gandor, C. Harms, M. Synowitz, U. Harms, P.C. Djoufack, D. Megow, U. Dirnagl, H. Hortnagl, K.B. Fink, and M. Endres Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurones J. Neurochem. 92 2005 1386 1398
5. Bush, D.E., Ziegelstein, R.C., Patel, U.V., Thombs, B.D., Ford, D.E., Fauerbach, J.A., McCann, U.D., Stewart, K.J., Tsilidis, K.K., Patel, A.L., Feuerstein, C.J., Bass, E.B., 2005. Post-myocardial infarction depression. Evidence Report Technology Assessment (Summary). 1-8.
6. R.M. Carney, and K.E. Freedland Depression, mortality, and medical morbidity in patients with coronary heart disease Biol. Psychiatry 54 2003 241 247
7. E. Castren, and T. Rantamaki The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity Dev. Neurobiol. 70 2010 289 297
8. Y.H. Dang, X.C. Ma, J.C. Zhang, Q. Ren, J. Wu, C.G. Gao, and K. Hashimoto Targeting of NMDA receptors in the treatment of major depression Curr. Pharm. Des. 20 2014 5151 5159
9. N. Frasure-Smith, and F. Lesperance Reflections on depression as a cardiac risk factor Psychosom. Med. 67 Suppl 1 2005 S19 S25
10. A. Ghanizadeh, and A. Hedayati Augmentation of fluoxetine with lovastatin for treating major depressive disorder, a randomized double-blind placebo controlled-clinical trial Depress. Anxiety 30 2013 1084 1088
11. A. Gougol, N. Zareh-Mohammadi, S. Raheb, M. Farokhnia, S. Salimi, N. Iranpour, H. Yekehtaz, and S. Akhondzadeh Simvastatin as an adjuvant therapy to fluoxetine in patients with moderate to severe major depression: a double-blind placebo-controlled trial J. Psychopharmacol. 2015 10.1177/0269881115578160
12. M. Haghighi, S. Khodakarami, L. Jahangard, M. Ahmadpanah, H. Bajoghli, E. Holsboer-Trachsler, and S. Brand In a randomized, double-blind clinical trial, adjuvant atorvastatin improved symptoms of depression and blood lipid values in patients suffering from severe major depressive disorder J. Psychiatr. Res. 58 2014 109 114
13. I. Hajjar, J. Schumpert, V. Hirth, D. Wieland, and G.P. Eleazer The impact of the use of statins on the prevalence of dementia and the progression of cognitive impairment J. Gerontol. A: Biol. Sci. Med. Sci. 57 2002 M414 M418
14. M. Hamilton A rating scale for depression J. Neurol. Neurosurg. Psychiatry 23 1960 56 62
15. X. Han, N. Yang, Y. Xu, J. Zhu, Z. Chen, Z. Liu, G. Dang, and C. Song Simvastatin treatment improves functional recovery after experimental spinal cord injury by upregulating the expression of BDNF and GDNF Neurosci. Lett. 487 2011 255 259
16. T. Hayashi, K. Hamakawa, S. Nagotani, G. Jin, F. Li, K. Deguchi, Y. Sehara, H. Zhang, I. Nagano, M. Shoji, and K. Abe HMG CoA reductase inhibitors reduce ischemic brain injury of Wistar rats through decreasing oxidative stress on neurons Brain Res. 1037 2005 52 58
17. L.D. Hillis, P.K. Smith, J.L. Anderson, J.A. Bittl, C.R. Bridges, J.G. Byrne, J.E. Cigarroa, V.J. DiSesa, L.F. Hiratzka, A.M. Hutter Jr., M.E. Jessen, E.C. Keeley, S.J. Lahey, R.A. Lange, M.J. London, M.J. Mack, M.R. Patel, J.D. Puskas, J.F. Sabik, O. Selnes, D.M. Shahian, J.C. Trost, M.D. Winniford, A.K. Jacobs, J.L. Anderson, N. Albert, M.A. Creager, S.M. Ettinger, R.A. Guyton, J.L. Halperin, J.S. Hochman, F.G. Kushner, E.M. Ohman, W. Stevenson, C.W. Yancy, and American College of Cardiology Foundation/American Heart Association Task Force on Practice, G. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J. Thorac. Cardiovasc. Surg. 143 2012 4 34
18. D. Khajavi, M. Farokhnia, A. Modabbernia, M. Ashrafi, S.-H. Abbasi, M. Tabrizi, and S. Akhondzadeh Oral scopolamine augmentation in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled study J. Clin. Psychiatry 73 2012 1428 1433
19. J.H. Lichtman, J.T. Bigger Jr., J.A. Blumenthal, N. Frasure-Smith, P.G. Kaufmann, F. Lesperance, D.B. Mark, D.S. Sheps, C.B. Taylor, E.S. Froelicher, American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, American Heart Association Council on Clinical Cardiology, American Heart Association Council on Epidemiology and Prevention, American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research, and American Psychiatric Association Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association Circulation 118 2008 1768 1775
20. P.Y. Lin, A.Y. Chang, and T.K. Lin Simvastatin treatment exerts antidepressant-like effect in rats exposed to chronic mild stress Pharmacol. Biochem. Behav. 124 2014 174 179
21. D. Lu, C. Qu, A. Goussev, H. Jiang, C. Lu, T. Schallert, A. Mahmood, J. Chen, Y. Li, and M. Chopp Statins increase neurogenesis in the dentate gyrus, reduce delayed neuronal death in the hippocampal CA3 region, and improve spatial learning in rat after traumatic brain injury J. Neurotrauma 24 2007 1132 1146
22. F.K. Ludka, A.D. Zomkowski, M.P. Cunha, T. Dal-Cim, A.L. Zeni, A.L. Rodrigues, and C.I. Tasca Acute atorvastatin treatment exerts antidepressant-like effect in mice via the l-arginine-nitric oxide-cyclic guanosine monophosphate pathway and increases BDNF levels Eur. Neuropsychopharmacol. 23 2013 400 412
23. I. Maany Antidepressants and the risk of suicidal behaviors JAMA 292 2004 2833 (author reply 2833)
24. R. Machado-Vieira, G. Salvadore, D.A. Luckenbaugh, H.K. Manji, and C.A. Zarate Jr. Rapid onset of antidepressant action: a new paradigm in the research and treatment of major depressive disorder J. Clin. Psychiatry 69 2008 946 958
25. M. Maes Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression Prog. Neuropsychopharmacol. Biol. Psychiatry 35 2011 664 675
26. M. Maes, R. Yirmyia, J. Noraberg, S. Brene, J. Hibbeln, G. Perini, M. Kubera, P. Bob, B. Lerer, and M. Maj The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression Metab. Brain Dis. 24 2009 27 53
27. A. Mandas, M.G. Congiu, C. Abete, S. Dessi, P.E. Manconi, M. Musio, S. Columbu, and W. Racugno Cognitive decline and depressive symptoms in late-life are associated with statin use: evidence from a population-based study of Sardinian old people living in their own home Neurol. Res. 36 2014 247 254
28. K. Martinowich, H. Manji, and B. Lu New insights into BDNF function in depression and anxiety Nat. Neurosci. 10 2007 1089 1093
29. A. Meijer, H.J. Conradi, E.H. Bos, B.D. Thombs, J.P. van Melle, and P. de Jonge Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research Gen. Hosp. Psychiatry 33 2011 203 216
30. A. Modabbernia, H. Sohrabi, A.-A. Nasehi, F. Raisi, S. Saroukhani, A. Jamshidi, M. Tabrizi, M. Ashrafi, and S. Akhondzadeh Effect of saffron on fluoxetine-induced sexual impairment in men: randomized double-blind placebo-controlled trial Psychopharmacology 223 2012 381 388
31. M.F. Muldoon, S.D. Barger, C.M. Ryan, J.D. Flory, J.P. Lehoczky, K.A. Matthews, and S.B. Manuck Effects of lovastatin on cognitive function and psychological well-being Am. J. Med. 108 2000 538 546
32. F. Mulhaupt, C.M. Matter, B.R. Kwak, G. Pelli, N.R. Veillard, F. Burger, P. Graber, T.F. Luscher, and F. Mach Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells Cardiovasc. Res. 59 2003 755 766
33. C. Otte, S. Zhao, and M.A. Whooley Statin use and risk of depression in patients with coronary heart disease: longitudinal data from the Heart and Soul Study J. Clin. Psychiatry 73 2012 610 615
34. A.K. Parsaik, B. Singh, M. Hassan Murad, K. Singh, S.S. Mascarenhas, M.D. Williams, M.I. Lapid, J.W. Richardson, C.P. West, and T.A. Rummans Statins use and risk of depression: a systematic review and meta-analysis J. Affect. Disord. 160 2014 62 67
35. G. Sanacora, G. Treccani, and M. Popoli Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders Neuropharmacology 62 2012 63 77
36. T. Santos, M.M. Baungratz, S.P. Haskel, D.D. de Lima, J.N. da Cruz, D.D. Magro, and J.G. da Cruz Behavioral interactions of simvastatin and fluoxetine in tests of anxiety and depression Neuropsychiatr. Dis. Treat. 8 2012 413 422
37. N. Shahmansouri, M. Farokhnia, S.H. Abbasi, S.E. Kassaian, A.A. Noorbala Tafti, A. Gougol, H. Yekehtaz, S. Forghani, M. Mahmoodian, S. Saroukhani, A. Arjmandi-Beglar, and S. Akhondzadeh A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients J. Affect. Disord. 155 2014 216 222
38. S.J. Schleifer, M.M. Macari-Hinson, D.A. Coyle, W.R. Slater, M. Kahn, R. Gorlin, and H.D. Zucker The nature and course of depression following myocardial infarction Arch. Intern. Med. 149 1989 1785 1789
39. Y.I. Sheline, M.H. Gado, and H.C. Kraemer Untreated depression and hippocampal volume loss Am. J. Psychiatry 160 2003 1516 1518
40. S. Sierra, M.C. Ramos, P. Molina, C. Esteo, J.A. Vazquez, and J.S. Burgos Statins as neuroprotectants: a comparative in vitro study of lipophilicity, blood-brain-barrier penetration, lowering of brain cholesterol, and decrease of neuron cell death J. Alzheimers Dis. 23 2011 307 318
41. L. Stafford, and M. Berk The use of statins after a cardiac intervention is associated with reduced risk of subsequent depression: proof of concept for the inflammatory and oxidative hypotheses of depression? J. Clin. Psychiatry 72 2011 1229 1235
42. R.A. Stewart, K.J. Sharples, F.M. North, D.B. Menkes, J. Baker, and J. Simes Long-term assessment of psychological well-being in a randomized placebo-controlled trial of cholesterol reduction with pravastatin. The LIPID Study Investigators Arch. Intern. Med. 160 2000 3144 3152
43. M.H. Trivedi Treating depression to full remission J. Clin. Psychiatry 70 2009 e01
44. S.J. Tsai Statins may enhance the proteolytic cleavage of proBDNF: implications for the treatment of depression Med. Hypotheses 68 2007 1296 1299
45. A.K. van Reedt Dortland, E.J. Giltay, T. van Veen, J. van Pelt, F.G. Zitman, and B.W. Penninx Associations between serum lipids and major depressive disorder: results from the Netherlands Study of Depression and Anxiety (NESDA) J. Clin. Psychiatry 71 2010 729 736
46. S. Vuletic, R.G. Riekse, S.M. Marcovina, E.R. Peskind, W.R. Hazzard, and J.J. Albers Statins of different brain penetrability differentially affect CSF PLTP activity Dement. Geriatr. Cogn. Disord. 22 2006 392 398
47. H. Wang, J.R. Lynch, P. Song, H.J. Yang, R.B. Yates, B. Mace, D.S. Warner, J.R. Guyton, and D.T. Laskowitz Simvastatin and atorvastatin improve behavioral outcome, reduce hippocampal degeneration, and improve cerebral blood flow after experimental traumatic brain injury Exp. Neurol. 206 2007 59 69
48. G. Weidner, S.L. Connor, G.T. Gerhard, P.B. Duell, and W.E. Connor The effects of dietary cholesterol-lowering on psychological symptoms: a randomised controlled study Psychol. Health Med. 14 2009 255 261
49. W.G. Wood, G.P. Eckert, U. Igbavboa, and W.E. Muller Statins and neuroprotection: a prescription to move the field forward Ann. N.Y. Acad. Sci. 1199 2010 69 76
50. Y. Young-Xu, K.A. Chan, J.K. Liao, S. Ravid, and C.M. Blatt Long-term statin use and psychological well-being J. Am. Coll. Cardiol. 42 2003 690 697
51. A. Zeinoddini, M. Sorayani, E. Hassanzadeh, M. Arbabi, M. Farokhnia, S. Salimi, A. Ghaleiha, and S. Akhondzadeh Pioglitazone adjunctive therapy for depressive episode of bipolar disorder: a randomized, double blind, placebo controlled trial Depress. Anxiety 32 3 2015 167 173 10.1002/da.22340